Cabotriq 40 mg Tablet 30's is used in the treatment of Renal Cell Carcinoma and Hepatocellular carcinoma. The detailed uses of Cabotriq 40 mg Tablet 30's are as follows:&lt;br/&gt;&bull; Renal Cell Carcinoma (RCC): Cabotriq 40 mg Tablet 30's is used for treating advanced kidney cancer.&lt;br/&gt;&bull; Hepatocellular Carcinoma (HCC): Cabotriq 40 mg Tablet 30's is used for liver cancer in patients previously treated with sorafenib.&lt;br/&gt;&bull; Medullary Thyroid Cancer (MTC): Cabotriq 40 mg Tablet 30's is especially used when the cancer is progressive and metastatic.&lt;br/&gt;

Medicinal Benefits:

Cabotriq 40 mg Tablet 30's contains Cabozantinib, which is used in treating advanced renal cell carcinoma and liver cancer. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Cabotriq 40 mg Tablet 30's stops the body's production, spread and growth of cancerous cells.

FAQs

What is the use of Cabotriq 40 mg Tablet 30's?

Cabotriq 40 mg Tablet 30's is used to treat Renal Cell Carcinoma and Hepatocellular carcinoma.

How does Cabotriq 40 mg Tablet 30's work?

Cabotriq 40 mg Tablet 30's contains Cabozantinib, which works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells.

Does Cabotriq 40 mg Tablet 30's cause thyroid problems?

Cabotriq 40 mg Tablet 30's may cause thyroid dysfunction, leading to decreased thyroid hormone levels. This effect causes hypothyroidism. So, notify your doctor if you feel extremely tired, colder than others, sudden weight gain/ weight loss, hair loss, or change in voice while using this medicine.